Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. I. Adaptation of the virus to mouse tumour cells as a pre-requisit for adjuvanticity.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D000951:Antigens, Neoplasm / Q000032:analysis; D005354:Fibrosarcoma / Q000276:immunology / Q000628:therapy*; D051379:Mice; D009368:Neoplasm Transplantation; D012513:Sarcoma, Experimental / Q000628:therapy*; D014616:Vaccinia virus / Q000276:immunology*
D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm